chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse referring to a 12 month old patient of unknown gender. Patient's medical history, concurrent condition and concomitant therapy were not provided. On 13-MAR-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck), 0.5 ml (lot# and expiration date unspecified, frequency reported as once), subcutaneously (incorrect product storage). No adverse effect was reported. Additional information has been requested.
Tachycardia: 130-150 on ambulatory, 1-teens at rest. Occurred for both injections but worse with first dose. First dose required vagal maneuver for improvement of symptoms and discomfort related to heart ?fluttering? and tachycardia
Erythematous, macular rash on upper left arm, which began following the 15 mth. The rash began the day of the immunizations. Rash is red and spreading with fever of 101 deg. at home.
1st 2 days- Fatigue, weakness, muscle aches. 7 days later on 2/6/2021: Severe Lt hip pain, pain w/ direct pressure or walking. 9 days later on 2/8/2021: Continuous Lt hip pain as well as new onset of Rt hip pain.
Pt did not experience adverse event.  A week after receiving  the vaccine, the pt told her provider that after receiving vaccine, some of the vaccine leaked out of her arm and that she did not receive the full dose.  Per CDC guidance for deviations, if dose amount actually given is indeterminant, then dose can be repeated.  Pt wanted to get repeat dose, and is scheduled for one.
1 week after receiving vaccine; Dizziness, almost faint, Shakiness, Headache, Extreme fatigue/exhaustion, feeling hot but no fever periodically.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On 22-JUN-2016, the patient was vaccinated with an improperly stored dose of GARDASIL (which had a lot # of L035105 and an expiration date of 14-MAY-2017; however, the dose, dosage number, route of administration and anatomical location were unknown). No concomitant medications were reported. The vaccine experienced a temperature excursion of 34 F for a time frame of 360 hours (also described as 15 days). No previous excursions had ever occurred and the aforementioned one was called out due to a data logger. Despite being vaccinated with such an improperly stored vaccine, no adverse events were reported. Additional information has been requested.
The pt experienced localized induration, blanched in center, blanched are 1 1/2 cm. The pt also experienced peripheral erythema that was 5cm in diameter. Afebrile, no urticaria. Treated with Benadryl. Observe for signs of infection. Symptoms resolved in 48 hours.
Information has been received from an unspecified reporter referring to a 14 year old patient of unknown gender. The patient's concomitant medication, concurrent conditions and medical history were not reported. On 29-AUG-2016, the patient was vaccinated with GARDASIL 9 (lot #, expiration date, dose and route were not reported) for prophylaxis. The vaccine was administered at a Heath Center during the temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA003650.
Stroke.  MRI shows small blood clot.  in lower back of brain leaving a small blank spot in my vision in upper right
Flu shot given @ approx. 2:20pm. By approx. 3:00pm. Pt developed headache, flushing, numbness, in lips & stated  "my throat feels like it's closing up".Benadryl 50mg IM given & pt transported to at ER. Pt was observed for approx. 2 hrs & released.
Patient was kind of anxious when patient had first booster; Patient was uncomfortable when patient had first booster; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (Patient was kind of anxious when patient had first booster) and DISCOMFORT (Patient was uncomfortable when patient had first booster) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Patient was kind of anxious when patient had first booster) and DISCOMFORT (Patient was uncomfortable when patient had first booster). At the time of the report, ANXIETY (Patient was kind of anxious when patient had first booster) and DISCOMFORT (Patient was uncomfortable when patient had first booster) outcome was unknown.            No concomitant information was reported. Patient had first booster of Moderna Vaccine. It was reported that in about 3 hours patient will take second Moderna booster and was debating about taking Tylenol before get home. No treatment information was provided.   Reporter did not allow further contact
A non-serious spontaneous report of flu symptoms was received from a consumer involving an 18-year-old female. No medical history or concomitant medications were reported. The patient received FLUMIST on 09-Aug-2010. On 11-Aug-2010 she developed watery eyes, sore throat, runny nose, aches, tiredness, and headache. The event resolved on 13-Aug-2010.
erythema, tenderness to (R) shoulder below injection site. Having nausea and body malaise
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 17-JUL-2014 the patient was vaccinated subcutaneously with an expired dose of ZOSTAVAX (dose 0.65ml, lot#J004266, expiration date 12-JUL-2014). No adverse effects were reported. No PQC (product quality complaint) was involved. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a 18 year old patient. The patient's concurrent condition, and medical history were not reported. On an unknown date, the patient was vaccinated with a dose of PROQUAD (dose, frequency, lot #, expiration date and indication unknown) reconstituted with sterile diluent (manufacturer unknown) (drug administered to patient of inappropriate age). No adverse effects were reported.
Pfizer vaccine was mixed with sterile water diluent instead of the sodium chloride diluent that is provided with vaccine. Patient did not have any adverse reaction. Parent was notified of error. Patient returned to clinic on 5-25-22 to get vaccine.
Myopericarditis; This is a literature report.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE), for COVID-19 immunisation. The following information was reported: MYOPERICARDITIS (hospitalization, medically significant), outcome "unknown". The patient underwent the following laboratory tests and procedures: Echocardiogram: Normal in reported cases; Electrocardiogram: unknown results; Imaging procedure: unknown results; Magnetic resonance imaging heart: unknown results; unknown results.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events Myopericarditis and the suspect drug cannot be excluded. The case will be reassessed once new information is available.,Linked Report(s) : US-PFIZER INC-PV202200057449 Same article/ drug/event and different patient;
Patient was administered with a vaccine that is dated to be expired on 3/14/23 on 3/18/23
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.
bruising; His arm was black and blue from shoulder to elbows".; severe arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (bruising), VACCINATION SITE DISCOLOURATION (His arm was black and blue from shoulder to elbows".) and VACCINATION SITE PAIN (severe arm pain) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE BRUISING (bruising), VACCINATION SITE DISCOLOURATION (His arm was black and blue from shoulder to elbows".) and VACCINATION SITE PAIN (severe arm pain). At the time of the report, VACCINATION SITE BRUISING (bruising), VACCINATION SITE DISCOLOURATION (His arm was black and blue from shoulder to elbows".) and VACCINATION SITE PAIN (severe arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided No concomitant medications were provided Action taken with mRNA-1273 is unknown   This case was linked to US-MODERNATX, INC.-MOD-2021-060528 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060528:MOD-2021-060528 (Wife case)
Swollen arm; Hot arm; Fever; Body aches/ Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Hot arm), PYREXIA (Fever) and MYALGIA (Body aches/ Sore arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Hot arm), PYREXIA (Fever) and MYALGIA (Body aches/ Sore arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Hot arm), PYREXIA (Fever) and MYALGIA (Body aches/ Sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: vitamin-b deficiency (Inconclusive) Vitamin-B deficiency.         Patient has went to doctor and  instructed to take vitamin-B.  No concomitant medication was provided.  No treatment medication was provided.  Patient went to doctor after experiencing side effects and had blood work and found out that b-vitamins were deficient and was instructed to take b-vitamins. Patient got second dose and experienced mild fever, body aches and a swollen and hot arm that was sore, that lasted 3 days.  Patient thought that b-vitamins were a part of what patient was experiencing.   This case was linked to MOD-2021-141432 (Patient Link).
Improperly stored vaccine administered; age at vaccine administration: 11 weeks; This spontaneous report as received from a registered nurse refers to a 11-week-old patient of unknown gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 03-FEB-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot number: T017688, expiration date: 21-MAY-2022), 0.5 ml (route of administration was not provided) (inappropriate age at vaccine administration). The vaccine was stored in temperature -13.3 degrees Celsius for 4 hours and 15 minutes. There was no previous temperature excursion. Digital data lodger was involved.  This is one of 23 reports from the same reporter.; Sender's Comments:  US-009507513-2012USA013093: US-009507513-2012USA013095: US-009507513-2012USA013524: US-009507513-2012USA013532: US-009507513-2012USA013533: US-009507513-2012USA013584: US-009507513-2012USA013585: US-009507513-2012USA013592: US-009507513-2012USA013594: US-009507513-2012USA013596: US-009507513-2012USA013598: US-009507513-2012USA013601: US-009507513-2012USA013603: US-009507513-2101USA000121: US-009507513-2101USA000122: US-009507513-2101USA000144: US-009507513-2101USA000214: US-009507513-2101USA000235: US-009507513-2101USA000261: US-009507513-2101USA000265: US-009507513-2101USA000266: US-009507513-2101USA000304:
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On 27-OCT-2014 patients were inadvertently vaccinated with improperly stored GARDASIL intramuscular injection (dose, strength, site and route of administration not reported). No adverse effect reported. This is one of the reports from the same source. Additional information has been requested.
3/11/21- pt was feeling fine.  She stood up got dizzy and seamed to have a seizure.  when she came to she did not know that it had happened.  about 5 hours later she stood up again got dizzy and seamed to have had another seizure.  her husband called 911.   EMTs took her vitals but did not detect anything to be wrong at the time and was advised to see PCP.    Next day 3/12/21 she went to her PCP.  She had blood work which showed high enzymes for heart failure so was sent to hospital to be admitted.  Pt had blood work, chest xray which showed blood clots in both lungs.  She was administered blood thinner.  MRI of head was clear. Echocardiogram was clear.  Pt stayed about 4 days.  Enzymes for heart failure was clearing up.  Pt was released and had a FU appt w/ PCP on 3/22/21.  Pt found out that she also had bilateral deep vein thrombosis in both legs while she was in the hospital. Pt is improving and is almost back to normal.
This case was reported by a consumer and described the occurrence of cough in a 87-year-old female patient who received ADVAIR multi dose powder inhaler for an unknown drug indication. A physician or other health care professional has not verified this report. Co-suspect medication included Flu shot. Concurrent medications included VENTOLIN. On an unknown date, the patient started Fluticasone propionate+salmeterol xinafoate. On 25 October 2010, the patient experienced cough. At the time of reporting, the outcome of the event was unknown.
I received the flu shot vaccine on 10/22/13 around 0800 in my left arm. The flu shot was administered by a facility employee. I noticed she gave the shot very high in the arm, and I remember this being odd because she asked me to roll up my cap sleeve shirt before she gave me the shot. My shoulder was very sore the remainder of the day. The following morning (10/23/14) I woke up in extreme pain and with extremely limited mobility in my left arm/shoulder. The pain was so bad while trying to put my clothes on, I got light-headed and felt I was going to pass out and had to lay back down. I assumed the pain would go away, but over the next several weeks the pain kept getting worse and the mobility in my left arm/shoulder became more and more limited. On 11/8/13 I called a local orthopedic office to schedule an appointment. This office specializes in upper extremity orthopedics and I had previously seen them about an unrelated hand issue. I scheduled an appointment to see Dr. on 11/12/13. On 11/12/13, Dr. checked my left arm/shoulder and recommended orthopedic therapy (OT) 1-2 times per week onsite for 3 weeks and he wanted to see me for a follow-up on 12/5/13. I had my OT evaluation on 11/18/13 and did an OT session following the evaluation. I was also given OT to do at home between onsite OT sessions, which I did as instructed. I had additional onsite OT sessions on 11/21/13, 11/25/13, 12/2/13, 12/5/13, 12/12/13. I continued OT daily at home during and after the onsite OT sessions. During the 12/5/13 follow-up appointment with Dr. he administered a cortisone shot since the pain in my arm was still so strong and my mobility was still extremely limited. Dr. hoped that cortisone shot would take care of the problem and he instructed me to call back if the shoulder didn't get better. After receiving the cortisone shot, the pain was much better, but the mobility was still limited. Around the end of January the pain began coming back so I called the doctor and set up an appointment to see Dr. on 3/13/14. During the 3/13/14 appointment Dr. checked my shoulder again (still in pain and still limited mobility) and then administered another cortisone shot. Dr. said to call if the pain/limited mobility continued and if so we would do an MRI at that time. The pain continued along with the limited mobility so dr. sent me for an MRI on 7/10/14. I went back to see Dr. on 7/17/14 to review the MRI results which showed fluid in my bursa. Essentially there is nothing else that can be done to ease my pain or increase my mobility unless I want to get yet another cortisone shot. My shoulder mobility is still very limited. It even hurts to sleep on my left shoulder at night. When I reach certain directions she shoulder pops and shoots extreme pain down the arm. I am still doing OT at home as of 9/17/14 while I am writing this.
This spontaneous report as received from a physician refers to a female patient of unknown age. On 02-FEB-2013, the patient was vaccinated with ZOSTAVAX (lot #, dose and route not reported). No other co-suspects were reported. No concomitant medications were reported. In February 2013 (sometime last week), the patient developed naturally occurring shingles (wild-type). A couple days later she visited a clinic and a nurse practitioner administered a dose of ZOSTAVAX to her and prescribed an unspecified antiviral medication. At an unspecified time after vaccination the patient's shingles symptoms worsened. It is unspecified if the patient started taking the antiviral medication. Physician refused to provide further information on the patient and the specific symptoms. The outcome of the event was reported as not recovered. The relatedness of the event with ZOSTAVAX was not provided. Additional information is not expected.
Chest pain and pressure 40 mins after the vaccine. I couldn't sleep later that evening and it was a lot of pressure and didn't want it to go unnoticed. Went to the ER at 01:00AM and wasn't seen until about 04:00AM. Blood work, EKG, negative, don't have blood clotting. I was doing better around 05:00AM 12/19/2021. I noticed the side effects continued when I laid down, it was hard to breathe and lose breath easy and often. My job requires lots of physical work and that continued for a week. I tried to get a hold of my PCP and he recommended me to a cardiologist for this last Thursday that just passed. That's who is seeing me now and doing the blood work and getting an echocardiogram soon.
Patient given on. 2/6/08 complained of redness, warmth, swelling and pain on 2/7/08. Treatment with Cipro 500mg 1 twice a day for 10 days
Redness and swelling at site of injection and warm to the touch. Cephalexin was prescribed.
12/11 Pt to ED from home with fatigue and SOB. Pt states she tested positive for covid 2-3 days ago. EMS reports pt was satting 89% on ra. Pt 92% on ra in triage. Pt denies pain. History of COVID + from 12/13/2021  Acute respiratory distress, most likely with cough, fatigue, weakness, most likely secondary to COVID-19 infection.  CONTINUE on isolation per protocol for COVID-19 infection/ breathing treatment oxygen and steroid/ZREMDESIVIR IV  12/15 Continue remdesivir for 5 days.  Monitor LFTs while patient is on remdesivir.  12/17 Completed remdesivir 5 days, Completed cefepime 5 days, Not a candidate for baricitinib 12/20 Pt discharged in stable condition. Need for stage renal disease management noted.
4 1/2cm induration-hard & moveable & tender on lt thigh 1-2cm raised bruise located over induration;
FEVER; This spontaneous report received from a parent concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980) dose was not reported, administered on 31-MAR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever. This report was non-serious.
Sore arm; Chills; Extremely tired; This is a spontaneous report from a contactable consumer. A 51-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13; lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date, at a single dose, for immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date after use of product, the patient experienced sore arm which she was unable to use or lift; chills; and was extremely tired. The outcome of events, sore arm which she was unable to use or lift, chills, and extremely tired, was unknown.  Information on the batch/lot number has been requested.
Day 1: patient had a red circle around the area/ Day 2: red rash spread around her arm to about 4 inches across.
eye pain, not able to move eyes from side to side that ended up with some floaters; eye pain, not able to move eyes from side to side that ended up with some floaters; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (eye pain, not able to move eyes from side to side that ended up with some floaters) and VITREOUS FLOATERS (eye pain, not able to move eyes from side to side that ended up with some floaters) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE PAIN (eye pain, not able to move eyes from side to side that ended up with some floaters) and VITREOUS FLOATERS (eye pain, not able to move eyes from side to side that ended up with some floaters). At the time of the report, EYE PAIN (eye pain, not able to move eyes from side to side that ended up with some floaters) had resolved and VITREOUS FLOATERS (eye pain, not able to move eyes from side to side that ended up with some floaters) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided.  Treatment information not provided.
After receiving the vaccine the patient experienced flushed feeling and perspired under both arms for 10 minutes.  Employee began to feel a sharp electrical shooting pain in the axillary/armpit area which extends into upper arm.  She is experiencing it intermittently with certain types of movement.  She believes that shot was given too low in the arm.